文献速递功能神经外科

复发性三叉神经痛显微血管减压术再探查及术中处理选择

Re-Exploration of Microvascular Decompression in Recurrent Trigeminal Neuralgia and Intraoperative Management Options.
PubMed 文献 · World Neurosurg · 2018-05-29

该回顾性分析纳入2007至2016年接受再探查显微血管减压术(re-MVD)的32例复发性三叉神经痛患者,术后87%的患者Barrow神经外科研究所疼痛指数(BNPI)改善至III级或更好,50%达BNPI 1或2级;11例术中未见神经受压或血管冲突者行神经松解术,90%报告BNPI改善;Kaplan-Meier分析显示再手术后中位无痛期为36个月,无显著并发症。

要点

  • 再探查显微血管减压术治疗复发性三叉神经痛安全有效。
  • 32例患者术后87% BNPI改善至III级或更好,50%达BNPI 1或2级。
  • 11例术中未见神经受压或血管冲突者行神经松解术,90%报告BNPI改善。

核心结论

  • 再探查显微血管减压术是治疗复发性三叉神经痛安全有效的方法。
  • 术中神经松解术是再探查中的重要工具,当三叉神经无明显持续受压或扭曲时应考虑使用。

研究设计与样本

  • 回顾性分析2007年至2016年前瞻性收集的接受再探查显微血管减压术患者的数据。
  • 共32例患者接受再探查显微血管减压术,所有患者术前BNPI均为IV或V级。

主要发现

  • 术后87%的患者BNPI改善至III级或更好,其中50%达到BNPI 1或2级。
  • 11例再探查时未见神经扭曲或血管冲突的患者接受术中神经松解术,其中90%报告BNPI改善。
  • Kaplan-Meier分析显示再探查显微血管减压术后中位无痛期为36个月。
  • 无显著并发症。

临床怎么用

  • 作者认为再探查显微血管减压术是治疗复发性三叉神经痛安全有效的方法。
  • 作者建议当再探查中未见三叉神经持续受压或扭曲时,应考虑行术中神经松解术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trigeminal neuralgia (TGN) is a debilitating disorder, and in patients for whom medical management is not sufficient, there are several therapeutic options. Microvascular decompression (MVD) for TGN has been shown to be highly effective; however, pain does recur after MVD in some patients. Therapeutic options for recurrent TGN are the same as those for primary TGN, including re-exploration of MVD (re-MVD). In this study we review our practice of re-MVD, comparing it with alternative options and assessing its safety and efficacy. METHODS: Retrospective analysis of prospectively collected data of patients undergoing re-MVD between 2007 and 2016. RESULTS: Thirty-two patients underwent re-MVD, all with a Barrow Neurosurgical Institute Pain Index (BNPI) of IV or V. Postoperatively, 87% of patients reported an improvement in their BNPI to III or better, with 50% being BNPI 1 or 2. Eleven patients without distortion or vascular conflict at the time of re-exploration underwent intraoperative neurolysis, and 90% reported improvement in their BNPI. Kaplan-Meier analysis showed a median pain-free period of 36 months after re-MVD. There were no significant complications. CONCLUSIONS: Re-MVD is a safe and effective method of treating recurrent TGN. Intraoperative neurolysis is an important tool in re-exploration and should be considered when there is no ongoing compression or distortion of the trigeminal nerve.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hussain MA, Konteas A, Sunderland G, et al. Re-Exploration of Microvascular Decompression in Recurrent Trigeminal Neuralgia and Intraoperative Management Options. World Neurosurg. 2018. PMID: 29857210. doi:10.1016/j.wneu.2018.05.147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。